Stocks
Dicerna Pharmaceuticals (DRNA) FCF conversion US GAAP (year values) |
|||||||||
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | LTM ? | 5 years average | |||
| FCF conversion, % | 83.8% | 76.7% | -20.5% | 5.91% | -147.8% | -7.22% | |||
| Changes by years, y/y, % | +3pp | -7pp | -97pp | +26pp | -154pp | 0% | |||
Dicerna Pharmaceuticals. FCF conversion, %
Dicerna Pharmaceuticals. FCF conversion, changes, pp
Dicerna Pharmaceuticals (DRNA) FCF conversion US GAAP (quarter values) |
||||||||
| FY2020Q3 | FY2020Q4 | FY2021Q1 | FY2021Q2 | FY2021Q3 | LTM ? | |||
| FCF conversion, % | 287.0% | 143.3% | 103.2% | -399.0% | 430.9% | -7.22% | ||
| Changes by years, y/y, % | +177pp | +103pp | +1 560pp | -538pp | +144pp | |||
| Changes by quarters, q/q, % | +148pp | -144pp | -40pp | -502pp | +830pp | |||
